Latest Ratios: P/E Ratio -141.8x · EV/EBITDA 52.7x · ROE -1.5%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $610M | $530M | $611M | $810M | $901M | $1.2B | $1.2B | $836M | $941M | $1.0B | $1.0B |
| Enterprise Value | $594M | $513M | $603M | $797M | $839M | $1.2B | $1.1B | $803M | $903M | $938M | $917M |
| P/E Ratio → | -141.78 | — | 19.98 | 16.77 | 10.21 | 7.75 | 12.78 | 25.84 | 18.48 | 19.19 | 11.48 |
| P/S Ratio | 1.12 | 0.97 | 1.14 | 1.49 | 1.51 | 1.65 | 2.03 | 2.04 | 1.90 | 1.92 | 1.51 |
| P/B Ratio | 2.19 | 1.87 | 1.91 | 2.44 | 2.84 | 3.32 | 4.37 | 2.93 | 3.56 | 4.35 | 3.78 |
| P/FCF | 15.87 | 13.78 | 17.61 | 44.71 | 18.20 | 8.41 | 9.67 | 28.55 | 8.61 | 14.82 | 14.43 |
| P/OCF | 11.24 | 9.76 | 11.01 | 23.88 | 11.66 | 7.01 | 8.04 | 16.86 | 7.86 | 9.90 | 9.58 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.94 | 1.12 | 1.46 | 1.41 | 1.63 | 2.00 | 1.96 | 1.82 | 1.80 | 1.38 |
| EV / EBITDA | 52.73 | 45.60 | 11.22 | 10.70 | 6.49 | 5.18 | 7.76 | 11.69 | 9.12 | 8.48 | 5.40 |
| EV / EBIT | — | — | 15.91 | 13.49 | 7.73 | 5.75 | 9.39 | 18.58 | 13.07 | 12.06 | 6.74 |
| EV / FCF | — | 13.35 | 17.37 | 43.99 | 16.94 | 8.28 | 9.52 | 27.41 | 8.26 | 13.88 | 13.18 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 16.4% | 16.4% | 21.4% | 24.6% | 30.2% | 38.3% | 33.7% | 24.3% | 27.1% | 29.5% | 33.0% |
| Operating Margin | -2.1% | -2.1% | 5.9% | 9.6% | 17.4% | 27.8% | 20.9% | 9.6% | 13.5% | 14.6% | 20.2% |
| Net Profit Margin | -0.8% | -0.8% | 5.7% | 8.9% | 14.8% | 21.3% | 15.9% | 7.9% | 10.3% | 10.0% | 13.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -1.5% | -1.5% | 9.4% | 14.9% | 26.0% | 49.6% | 32.9% | 11.7% | 20.6% | 21.0% | 35.4% |
| ROA | -1.2% | -1.2% | 7.8% | 10.9% | 19.1% | 39.4% | 25.9% | 9.4% | 16.4% | 16.3% | 26.1% |
| ROIC | -3.0% | -3.0% | 7.5% | 13.6% | 25.9% | 51.6% | 35.9% | 12.4% | 25.6% | 33.2% | 59.8% |
| ROCE | -3.8% | -3.8% | 9.6% | 15.8% | 30.1% | 64.3% | 43.0% | 14.3% | 27.0% | 30.2% | 52.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | — | — | — |
| Debt / EBITDA | 0.16 | 0.16 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | 0.03 | — | — | — |
| Net Debt / Equity | — | -0.06 | -0.03 | -0.04 | -0.20 | -0.05 | -0.07 | -0.12 | -0.15 | -0.28 | -0.33 |
| Net Debt / EBITDA | -1.48 | -1.48 | -0.15 | -0.17 | -0.48 | -0.09 | -0.13 | -0.48 | -0.39 | -0.57 | -0.51 |
| Debt / FCF | — | -0.43 | -0.24 | -0.72 | -1.26 | -0.14 | -0.15 | -1.13 | -0.35 | -0.94 | -1.25 |
| Interest Coverage | -123.53 | -123.53 | 371.34 | 287.95 | 423.96 | 1260.72 | 634.41 | 225.10 | 209.22 | 511.83 | 731.76 |
Net cash position: cash ($18M) exceeds total debt ($2M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.87 | 3.87 | 4.25 | 4.29 | 2.22 | 4.26 | 2.87 | 4.07 | 3.26 | 3.17 | 2.76 |
| Quick Ratio | 1.80 | 1.80 | 2.99 | 3.03 | 1.82 | 3.69 | 2.51 | 3.61 | 2.82 | 2.41 | 2.09 |
| Cash Ratio | 1.69 | 1.69 | 1.73 | 1.86 | 1.38 | 2.87 | 1.73 | 2.69 | 2.15 | 1.21 | 1.08 |
| Asset Turnover | — | 1.60 | 1.39 | 1.36 | 1.23 | 1.65 | 1.63 | 1.18 | 1.48 | 1.84 | 1.87 |
| Inventory Turnover | 4.03 | 4.03 | 5.51 | 5.14 | 6.40 | 10.29 | 12.98 | 10.99 | 11.50 | 9.27 | 8.16 |
| Days Sales Outstanding | — | 43.12 | 45.75 | 40.18 | 40.09 | 28.49 | 37.13 | 46.80 | 33.16 | 41.99 | 38.15 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.6% | 1.9% | 1.9% | 13.7% | 4.7% | 4.9% | 9.9% | 1.7% | 2.0% | 2.4% | 3.3% |
| Payout Ratio | — | — | 38.7% | 229.8% | 48.4% | 37.9% | 126.0% | 44.3% | 37.7% | 45.8% | 37.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 5.0% | 6.0% | 9.8% | 12.9% | 7.8% | 3.9% | 5.4% | 5.2% | 8.7% |
| FCF Yield | 6.3% | 7.3% | 5.7% | 2.2% | 5.5% | 11.9% | 10.3% | 3.5% | 11.6% | 6.7% | 6.9% |
| Buyback Yield | 4.3% | 4.9% | 5.6% | 1.5% | 0.0% | 0.0% | 0.0% | 0.2% | 0.1% | 6.5% | 1.4% |
| Total Shareholder Yield | 5.9% | 6.8% | 7.6% | 15.1% | 4.8% | 4.9% | 9.9% | 2.0% | 2.1% | 8.9% | 4.7% |
| Shares Outstanding | — | $16M | $17M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $19M |
Cyclical demand and margin compression
As reported in recent financial statements, RGR's gross margin has experienced significant volatility, compressing from 24.7% in 2023Q4 to 19.9% in 2026Q1, which suggests that the company is struggling to maintain pricing power or effectively absorb fixed manufacturing costs amidst a cooling consumer demand environment.
The shift to a negative operating margin of -1.4% in the most recent quarter indicates that the company's current cost structure is not aligned with its present volume levels. Investors should monitor whether this margin erosion is a temporary byproduct of the Marlin brand integration or a more permanent structural shift in the competitive landscape.
Based on the provided quarterly data, the cash conversion cycle has fluctuated significantly, reaching 80 days in 2026Q1, which highlights the inherent challenges of managing inventory within a two-tier distribution model that often obscures real-time sell-through rates and creates potential for channel inventory buildup.
The variability in days inventory outstanding, which peaked at 74 days in 2023Q4, suggests that the company's production cadence may be occasionally misaligned with wholesale demand. This inefficiency warrants further investigation into whether the current inventory levels are sustainable or if future write-downs may be required to clear excess stock.
According to historical performance metrics, RGR's return on invested capital has trended downward, reaching -0.6% in 2026Q1, which indicates that the company is currently failing to generate returns above its cost of capital, a stark contrast to the more stable performance observed in previous fiscal periods.
The decline in ROIC appears to be driven primarily by the compression of operating margins rather than asset turnover, suggesting that the core manufacturing business is struggling to maintain its historical efficiency. This trend warrants caution, as it implies that recent capital allocation efforts may not be yielding the expected value creation.
As indicated by current market data, RGR's negative TTM P/E ratio of -141.96 and an EV/EBITDA of 52.80 suggest that the market is pricing in significant uncertainty regarding the company's ability to return to historical profitability levels compared to its primary peer, Smith & Wesson Brands.
The forward P/E of 22.55 implies that investors are banking on a recovery in earnings, yet the current lack of organic growth momentum makes this valuation appear optimistic. The premium relative to the sector may be misaligned with the company's recent inability to cover its fixed costs, suggesting a potential valuation reset if margins do not improve.
Based on industry analysis, the most commonly misapplied metric for RGR is the headline NICS background check data, which investors frequently use as a direct proxy for revenue despite the company's two-tier distribution model creating a significant lag between wholesale shipments and actual end-consumer retail sales.
Relying solely on NICS data obscures the impact of channel inventory levels, which can lead to erroneous conclusions about the company's immediate revenue trajectory. Analysts should instead focus on distributor inventory levels and sell-through data to better understand the underlying health of the business model.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying RGR stock.
Sturm, Ruger & Company, Inc.'s current P/E ratio is -141.8x. The historical average is 16.4x.
Sturm, Ruger & Company, Inc.'s current EV/EBITDA is 52.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.9x.
Sturm, Ruger & Company, Inc.'s return on equity (ROE) is -1.5%. The historical average is 21.8%.
Based on historical data, Sturm, Ruger & Company, Inc. is trading at a P/E of -141.8x. Compare with industry peers and growth rates for a complete picture.
Sturm, Ruger & Company, Inc.'s current dividend yield is 1.63%.
Sturm, Ruger & Company, Inc. has 16.4% gross margin and -2.1% operating margin.
Sturm, Ruger & Company, Inc.'s Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.